Cencora COR U. S. Healthcare Solutions — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cencora in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Cencora’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cencora's u. s. healthcare solutions — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cencora's u. s. healthcare solutions — revenue?
- Cencora (COR) reported u. s. healthcare solutions — revenue of $68.77B in Q1 2026.
- How has Cencora's u. s. healthcare solutions — revenue changed year-over-year?
- Cencora's u. s. healthcare solutions — revenue increased by 2.9% year-over-year, from $66.82B to $68.77B.
- What is the long-term trend for Cencora's u. s. healthcare solutions — revenue?
- Over 4 years (2021 to 2025), Cencora's u. s. healthcare solutions — revenue has grown at a -4.9% compound annual growth rate (CAGR), from $352.58B to $288.04B.
- What does u. s. healthcare solutions — revenue mean?
- The total gross sales generated by the U.S. Healthcare Solutions segment from the distribution of pharmaceuticals and related healthcare services. This is the primary top-line metric for the segment's market activity.